Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

October 2005 · Vol. 17, No. 10

Current management of diabetic pregnancy

Unlike conventional therapy, intensive drug therapy plus self-monitoring diminishes adverse obstetric outcomes in all types of diabetes


Fast Track

I advise 20 to 30 minutes of exercise 3 to 4 times weekly, if women are willing and able, as it can improve postprandial blood glucose levels and insulin sensitivity

In my opinion, insulin lispro can and should be used in pregnancy because it produces more physiologic insulin patterns

Hypoglycemic episodes occurred in 63% of insulin-treated women with gestational diabetes, but in only 28% of women taking glyburide

Compromised lung maturity in a live infant is preferable to healthy lungs in a deceased infant

IN THIS ARTICLE

Oded  Langer,  MD, PhD

Chairman, Department of Obstetrics and Gynecology, St. Luke’s-Roosevelt Hospital Center, University Hospital of Columbia University,  New York City

New agents such as insulin analogs (mainly insulin lispro) and oral antidiabetic drugs (mainly glyburide) have profoundly altered the management of diabetes, producing obstetric outcomes comparable to those among the general population. Furthermore, in all types of diabetes, self-monitoring of blood glucose plus intensified drug therapy may help women achieve glycemic control and enhance perinatal outcomes at a lower cost than conventional management—and patients readily accept this approach.

This article describes the rationale for intensive treatment with these agents and other interventions to prevent both hypoglycemia and hyperglycemia.

Sign in now to read more...

Back to top


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement